Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | |
| Cash Flows From Operating Activities | |
| Net Income | -4,500 |
| Depreciation Amortization | 4 |
| Accounts payable and accrued liabilities | 193 |
| Other Working Capital | 174 |
| Other Operating Activity | 1,464 |
| Operating Cash Flow | $-2,664 |
| Cash Flows From Investing Activities | |
| PPE Investments | -39 |
| Investing Cash Flow | $-39 |
| Cash Flows From Financing Activities | |
| Other Financing Activity | 9,709 |
| Financing Cash Flow | $9,709 |
| Beginning Cash Position | 2,334 |
| End Cash Position | 9,340 |
| Net Cash Flow | $7,006 |
| Free Cash Flow | |
| Operating Cash Flow | -2,664 |
| Capital Expenditure | -39 |
| Free Cash Flow | -2,703 |